Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar;104(3):246-251.
doi: 10.1016/j.jhin.2020.01.022. Epub 2020 Feb 6.

Persistence of Coronaviruses on Inanimate Surfaces and Their Inactivation With Biocidal Agents

Affiliations
Free PMC article
Review

Persistence of Coronaviruses on Inanimate Surfaces and Their Inactivation With Biocidal Agents

G Kampf et al. J Hosp Infect. .
Free PMC article

Abstract

Currently, the emergence of a novel human coronavirus, SARS-CoV-2, has become a global health concern causing severe respiratory tract infections in humans. Human-to-human transmissions have been described with incubation times between 2-10 days, facilitating its spread via droplets, contaminated hands or surfaces. We therefore reviewed the literature on all available information about the persistence of human and veterinary coronaviruses on inanimate surfaces as well as inactivation strategies with biocidal agents used for chemical disinfection, e.g. in healthcare facilities. The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62-71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute. Other biocidal agents such as 0.05-0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate are less effective. As no specific therapies are available for SARS-CoV-2, early containment and prevention of further spread will be crucial to stop the ongoing outbreak and to control this novel infectious thread.

Keywords: Biocidal agents; Chemical inactivation; Coronavirus; Disinfection; Inanimate surfaces; Persistence.

Similar articles

See all similar articles

Cited by 118 articles

See all "Cited by" articles

References

    1. WHO . WHO; 2020. Coronavirus Disease 2019 (COVID-19) Situation Report 23.
    1. de Wit E., van Doremalen N., Falzarano D., Munster V.J. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523–534. - PMC - PubMed
    1. Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 - PMC - PubMed
    1. Otter J.A., Donskey C., Yezli S., Douthwaite S., Goldenberg S.D., Weber D.J. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2016;92:235–250. - PMC - PubMed
    1. Dowell S.F., Simmerman J.M., Erdman D.D., Wu J.S., Chaovavanich A., Javadi M. Severe acute respiratory syndrome coronavirus on hospital surfaces. Clin Infect Dis. 2004;39:652–657. - PMC - PubMed

MeSH terms

Supplementary concepts

Feedback